DISCONTINUED OPERATIONS (Assets and Liabilities of the Discontinued Operations) (Details) - Genetic Assays and Platforms and Patient Testing - Included in assets held for sale - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Accounts receivable, net	$ 0	$ 1,905
Other current assets	31	82
Total Assets	31	1,987
Accrued compensation	0	264
Total Liabilities	$ 0	$ 264